Moshe Manor
2016
In 2016, Moshe Manor earned a total compensation of $682.3K as President and Chief Executive Officer at Protalix BioTherapeutics, a 21% decrease compared to previous year.
Compensation breakdown
| Option Awards | $250,299 |
|---|---|
| Salary | $333,058 |
| Other | $98,925 |
| Total | $682,282 |
Manor received $333.1K in salary, accounting for 49% of the total pay in 2016.
Manor also received $250.3K in option awards and $98.9K in other compensation.
Rankings
In 2016, Moshe Manor's compensation ranked 9,997th out of 14,075 executives tracked by ExecPay. In other words, Manor earned more than 29.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,997 out of 14,075 | 29th |
Division Manufacturing | 3,855 out of 5,488 | 30th |
Major group Chemicals And Allied Products | 1,354 out of 1,900 | 29th |
Industry group Drugs | 1,081 out of 1,543 | 30th |
Industry Biological Products, Except Diagnostic Substances | 189 out of 287 | 34th |
Source: SEC filing on March 16, 2017.
Manor's colleagues
We found four more compensation records of executives who worked with Moshe Manor at Protalix BioTherapeutics in 2016.
2016
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2016
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2016
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2016
Tzvi Palash
Protalix BioTherapeutics